Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies

Scientific Reports
James YarmolinskyMaria Inês Schmidt

Abstract

An emerging body of evidence has implicated plasminogen activator inhibitor-1 (PAI-1) in the development of type 2 diabetes (T2D), though findings have not always been consistent. We systematically reviewed epidemiological studies examining the association of PAI-1 with T2D. EMBASE, PubMed, Web of Science, and the Cochrane Library were searched to identify studies for inclusion. Fifty-two studies (44 cross-sectional with 47 unique analytical comparisons and 8 prospective) were included. In pooled random-effects analyses of prospective studies, a comparison of the top third vs. bottom third of baseline PAI-1 values generated a RR of T2D of 1.67 (95% CI 1.28-2.18) with moderate heterogeneity (I(2) = 38%). Additionally, of 47 cross-sectional comparisons, 34(72%) reported significantly elevated PAI-1 among diabetes cases versus controls, 2(4%) reported significantly elevated PAI-1 among controls, and 11(24%) reported null effects. Results from pooled analyses of prospective studies did not differ substantially by study design, length of follow-up, adjustment for various putative confounding factors, or study quality, and were robust to sensitivity analyses. Findings from this systematic review of the available epidemiological liter...Continue Reading

References

Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J AuwerxJ Geboers
Aug 1, 1993·Metabolism: Clinical and Experimental·B J Potter van LoonA E Meinders
Feb 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·A R FolsomK K Wu
Mar 1, 1996·Proceedings of the Society for Experimental Biology and Medicine·Y ItoT Sakata
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
May 13, 1998·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·B Janand-DelenneP Vague
Jun 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·A MavriB R Binder
Jan 14, 2000·JAMA : the Journal of the American Medical Association·J B MeigsP W Wilson
Feb 9, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J P Bastard, L Piéroni
Aug 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K SchäferD J Loskutoff
Oct 19, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·I MertensL Van Gaal
Apr 5, 2002·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Suzanne L BrandenburgJudith G Regensteiner
Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·I Mertens, L F Van Gaal
Jul 30, 2002·Diabetes Care·Latha P PalaniappanStephen P Fortmann

❮ Previous
Next ❯

Citations

Aug 2, 2017·International Journal of Molecular Sciences·Yao YeViktoria von Schönfeldt
Aug 31, 2018·PloS One·Aoife M CurranLorraine Brennan
May 28, 2017·Journal of the American Heart Association·Ci SongAndrew D Johnson
Feb 11, 2020·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Lorenz JennyVerena Schroeder
Mar 14, 2019·International Journal of Molecular Medicine·Rabab Asghar AbdulwahabHayder A Giha
Jun 2, 2020·The British Journal of Nutrition·Jiali ZhengCarrie R Daniel
May 23, 2020·Bioengineering & Translational Medicine·Amrita Banerjee, Jagdish Singh
Jun 9, 2020·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Anastasia OtamasRamzi A Ajjan
Oct 1, 2020·International Journal of Molecular Sciences·Fasih Ahmad Rahman, Matthew Paul Krause
Aug 23, 2020·International Journal of Molecular Sciences·Machteld SillenPaul J Declerck
May 9, 2019·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Richard G JungBenjamin Hibbert
May 16, 2017·Metabolic Syndrome and Related Disorders·Omar BayomyGail K Adler
Oct 13, 2020·International Wound Journal·Yimeng Gao, Hongzhong Jin
Jan 13, 2021·Scientific Reports·Joshua A LevineDouglas E Vaughan
Mar 18, 2021·Journal of Endocrinological Investigation·L L O'MahoneyM D Campbell
Apr 4, 2021·International Journal of Molecular Sciences·Machteld Sillen, Paul J Declerck
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Jessica MaiuoloVincenzo Mollace
Mar 2, 2018·Thrombosis Research·Richard G JungBenjamin Hibbert
Jun 8, 2021·Metabolic Syndrome and Related Disorders·David KarasekLudek Slavik
Jul 6, 2021·Annals of Pediatric Endocrinology & Metabolism·Mariano Nicolás AlemanAdela Victoria Abregu
May 1, 2021·Journal of Obesity & Metabolic Syndrome·Zeinab NikniazLeila Mokhtari
Oct 19, 2021·Frontiers in Cardiovascular Medicine·Yuen-Kwun Wong, Hung-Fat Tse
Nov 7, 2021·Scientific Reports·Masaaki KubotaYasuo Iwadate

❮ Previous
Next ❯

Software Mentioned

Revman
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.